On Monday 12 May, at 12:00, the Biogem will host Antonella Spinazzola, Professor of Mitochondrial Medicine and Neuroscience at University College London and an international leading figure in the study of mitochondrial DNA. Originally from Melito Irpino, Spinazzola will present her research on genetic diseases linked to the dysfunction of mitochondria, organelles essential for the production of energy in cells. Her studies have resulted in the identification of the genetic causes and pathogenic mechanisms of several rare genetic diseases. Results that made possible the development of therapeutic strategies for two groups of mitochondrial DNA diseases, also validated in preclinical models.

The seminar, open to the public and held in English to facilitate the attendance of several international researchers, will also present the first steps towards the clinical translation of these innovative therapies.

<<The goal of my research - explains Spinazzola - is understanding the role of mitochondria and their genome in human diseases, studying both rare genetic diseases and the most common neurometabolic disorders, with the aim of developing tailored therapies and innovative strategies that may be applied to a broad spectrum of clinical conditions>>.

<<This seminar - underlines the scientific director of Biogem, Giovambattista Capasso - is a valuable opportunity to delve into the most promising developments in the field of translational mitochondrial medicine and to know the work of an Italian scientist at the top of international research>>.